Deutsche Bank’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-452,119
Closed -$836K 4018
2023
Q1
$836K Buy
452,119
+7,399
+2% +$13.7K ﹤0.01% 2204
2022
Q4
$494K Sell
444,720
-62,686
-12% -$69.6K ﹤0.01% 2449
2022
Q3
$1.19M Buy
507,406
+421,671
+492% +$986K ﹤0.01% 1869
2022
Q2
$260K Buy
85,735
+4,878
+6% +$14.8K ﹤0.01% 2998
2022
Q1
$549K Buy
80,857
+30,265
+60% +$205K ﹤0.01% 2679
2021
Q4
$422K Buy
50,592
+31,635
+167% +$264K ﹤0.01% 2923
2021
Q3
$141K Sell
18,957
-614
-3% -$4.57K ﹤0.01% 3698
2021
Q2
$133K Buy
19,571
+8,355
+74% +$56.8K ﹤0.01% 3951
2021
Q1
$115K Sell
11,216
-1,041
-8% -$10.7K ﹤0.01% 3852
2020
Q4
$86K Buy
12,257
+3,475
+40% +$24.4K ﹤0.01% 3850
2020
Q3
$72K Buy
8,782
+839
+11% +$6.88K ﹤0.01% 3644
2020
Q2
$55K Buy
7,943
+1,252
+19% +$8.67K ﹤0.01% 3716
2020
Q1
$32K Sell
6,691
-33,379
-83% -$160K ﹤0.01% 3659
2019
Q4
$348K Sell
40,070
-43,492
-52% -$378K ﹤0.01% 2889
2019
Q3
$277K Sell
83,562
-31,589
-27% -$105K ﹤0.01% 2963
2019
Q2
$569K Sell
115,151
-47,701
-29% -$236K ﹤0.01% 3163
2019
Q1
$1.01M Buy
162,852
+12,557
+8% +$77.7K ﹤0.01% 2967
2018
Q4
$506K Buy
150,295
+40,282
+37% +$136K ﹤0.01% 3274
2018
Q3
$716K Buy
110,013
+65,860
+149% +$429K ﹤0.01% 3520
2018
Q2
$339K Buy
44,153
+17,917
+68% +$138K ﹤0.01% 3960
2018
Q1
$585K Sell
26,236
-6,440
-20% -$144K ﹤0.01% 3560
2017
Q4
$416K Buy
32,676
+11,805
+57% +$150K ﹤0.01% 3604
2017
Q3
$323K Buy
20,871
+7,233
+53% +$112K ﹤0.01% 3530
2017
Q2
$189K Buy
13,638
+5,542
+68% +$76.8K ﹤0.01% 3802
2017
Q1
$177K Buy
+8,096
New +$177K ﹤0.01% 3502